- Home
- VNDA vs KINS Comparison
VNDA vs KINS Comparison
Compare VNDA & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VNDA | KINS |
|---|---|---|
| Founded | 2002 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.1M | 284.5M |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | VNDA | KINS |
|---|---|---|
| Price | $4.04 | $18.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $11.75 | N/A |
| AVG Volume (30 Days) | ★ 841.3K | 71.4K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | N/A | ★ 94.59 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $216,105,000.00 | $214,867,301.00 |
| Revenue This Year | $15.16 | $18.83 |
| Revenue Next Year | $35.50 | $15.85 |
| P/E Ratio | ★ N/A | $28.15 |
| Revenue Growth | 8.72 | ★ 38.50 |
| 52 Week Low | $4.01 | $13.83 |
| 52 Week High | $9.91 | $20.90 |
Technical Indicators
Market Signals| Indicator | VNDA | KINS |
|---|---|---|
| Relative Strength Index (RSI) | 22.64 | 49.95 |
| Support Level | N/A | $18.68 |
| Resistance Level | $5.37 | $19.31 |
| Average True Range (ATR) | 0.18 | 0.46 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 4.66 | 75.41 |
Price Performance
Historical ComparisonAbout VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About KINS Kingstone Companies Inc.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.